Brooklyn Investment Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Brooklyn Investment Group’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,149	Closed	-$39.8K	–	2911
2024 Q4	$39.8K	Buy	+4,149	New	+$21.6K	0.01%	592

Other funds holding PSTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Brooklyn Investment Group's PSTX Position: Q1 2025 in Review

Brooklyn Investment Group sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 4,149 shares — an estimated $39.8K sold.

Brooklyn Investment Group first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $39.8K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

Brooklyn Investment Group reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Brooklyn Investment Group sold 4,149 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $39.8K.
Brooklyn Investment Group first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Brooklyn Investment Group's Poseida Therapeutics, Inc. Common Stock position peaked at $39.8K in Q4 2024.
1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Brooklyn Investment Group's 13F filing for Q1 2025, filed 13 May 2025.